Abstract
The authors analyze the framework for public participation in Australian biotechnology policy and argue that participation is undermined by the institutional structures that were ostensibly designed to facilitate consultation. They conclude that for the moment, community consultation in the formulation of Australian biotechnology policy appears limited. Indeed, the Australian Gene Technology Act 2000 and the Gene Technology Community Consultative Committee Operating Procedures effectively exclude the community from participating in deliberations on biotechnology policy. The community continues to be treated as consumers of advice, rather than technological citizens who can make a genuine contribution to biotechnology policy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
